ABUS
Arbutus Biopharma Corp
4.90$
-0.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 2,033.3% | – | 5,903.0% | 1,486.5% | 225.4% | 703.3% | 971.4% | 1,314.8% | 1,043.9% | 659.3% | 2,166.7% | 1,951.0% | 579.3% | 767.5% | 698.6% | 691.2% | 792.2% | 687.0% | 652.2% | 678.4% | 500.3% | 599.3% | 3.1% | 2.7% | 5.8% | 367.5% | 5.0% | 7.4% | 7.9% | 818.8% | 1,005.4% | 20.6% | – | 559.7% | 507.9% | 0.1% | 2.1% | 1.0% | 0.0% | – | – | |
| -1,933.3% | – | -5,803.0% | -1,386.5% | -125.4% | -603.3% | -871.4% | -1,214.8% | -943.9% | -559.3% | -2,066.7% | -1,851.0% | -479.3% | -667.5% | -598.6% | -591.2% | -692.2% | -587.0% | -552.2% | -578.4% | 100.0% | -499.3% | 100.0% | 100.0% | 100.0% | -267.5% | 100.0% | 100.0% | 100.0% | -718.8% | 100.0% | 100.0% | 100.0% | -459.7% | -407.9% | 100.0% | 97.9% | 99.0% | 100.0% | 100.0% | 100.0% | |
| 2,033.3% | – | 5,903.0% | 1,486.5% | 225.4% | 703.3% | 971.4% | 1,314.8% | 1,043.9% | 659.3% | 2,166.7% | 1,951.0% | 579.3% | 3,476.8% | 698.6% | 691.2% | 792.2% | 687.0% | 652.2% | 678.4% | 500.3% | 599.3% | 146.7% | 161.1% | 336.9% | 367.5% | 273.3% | 380.4% | 433.0% | 818.8% | 1,005.4% | 901.0% | 1,065.9% | 559.7% | 507.9% | 51.2% | 1,092.2% | 476.3% | 2.3% | 285.8% | 9.8% | |
| 480.6% | – | 1,841.7% | 442.6% | 53.1% | 139.8% | 255.5% | 303.5% | 165.8% | 353.2% | 649.8% | 1,254.1% | 106.1% | 116.0% | 238.3% | 235.5% | 266.9% | 153.4% | 183.5% | 192.3% | 125.2% | 143.4% | 38.9% | 36.5% | 58.7% | 68.0% | 83.0% | 128.6% | 125.4% | 237.8% | 346.7% | 437.3% | 338.8% | 535.7% | 330.6% | 31.0% | 575.4% | 351.0% | 3.3% | 381.4% | 9.1% | |
| 2,551.6% | – | 7,886.8% | 1,975.4% | 287.1% | 867.6% | 1,268.8% | 1,664.7% | 1,241.0% | 1,042.6% | 2,891.5% | 3,282.4% | 702.0% | 138.1% | 283.2% | 276.8% | 307.0% | 96.2% | 189.6% | 222.1% | 651.1% | 149.4% | 187.2% | 199.1% | 399.2% | 93.8% | 360.4% | 495.3% | 562.8% | 248.4% | 1,363.9% | 1,350.5% | 1,701.2% | 425.5% | 1,556.9% | 86.1% | 1,665.6% | 826.3% | 5.6% | 688.2% | 19.0% | |
| -2,451.6% | – | -7,786.8% | -1,875.4% | -187.1% | -2,377.6% | -1,281.7% | -1,772.2% | -2,043.2% | -1,007.3% | -2,808.7% | -3,141.7% | -2,986.0% | -805.6% | -881.8% | -868.0% | -999.1% | -683.2% | -741.9% | -800.4% | -551.1% | -648.7% | -87.2% | -99.1% | -299.2% | -361.3% | -260.4% | -395.3% | -462.8% | -967.2% | -1,263.9% | -1,250.5% | -1,601.2% | -885.2% | -1,964.7% | 13.9% | -1,567.7% | -727.3% | 94.4% | -588.2% | 81.0% | |
| 54.9% | – | 17.9% | 6.5% | 1.1% | 3.0% | 7.2% | 64.7% | 47.6% | 7.3% | 1.8% | 0.3% | 35.9% | 61.4% | 69.8% | 72.6% | 70.5% | 33.4% | 36.5% | 32.8% | 22.8% | 17.5% | 4.0% | 3.4% | 7.2% | 4.9% | 3.0% | 3.7% | 1.0% | 2.1% | 2.9% | 2.0% | 2.2% | 1.9% | 1.6% | 0.3% | 4.3% | 1.7% | 0.0% | 1.8% | 0.0% | |
| -2,531.7% | – | -7,926.4% | -1,757.0% | -168.3% | -2,377.7% | -1,213.7% | 248.5% | -1,811.9% | -1,087.5% | -3,424.3% | -3,570.4% | -3,108.8% | -1,523.7% | -929.6% | -930.4% | -1,231.5% | -714.2% | -775.2% | -832.4% | -573.6% | -665.0% | -90.0% | -99.7% | -295.1% | -351.2% | -244.3% | -367.5% | -431.6% | -900.3% | -1,166.8% | -1,146.9% | -1,472.5% | -796.2% | -1,390.4% | 23.5% | -1,463.5% | -357.4% | 94.7% | -507.2% | 84.2% | |
| 46.5% | – | -432.8% | 17.1% | -1.8% | -959.7% | 66.3% | -1,828.7% | -269.8% | -93.4% | -701.6% | -530.2% | -413.5% | -616.7% | 69.8% | 72.6% | -96.6% | 33.4% | 36.5% | 32.8% | 22.8% | 17.5% | 35.3% | 0.6% | -4.1% | 15.7% | -13.1% | 3.7% | -7.9% | 50.1% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | – | |
| -2,531.7% | – | -7,926.4% | -1,757.0% | -168.3% | -1,418.0% | -1,213.7% | 248.5% | -1,542.1% | -1,087.5% | -3,424.3% | -3,570.4% | -2,695.3% | -1,523.7% | -929.6% | -930.4% | -1,231.5% | -714.2% | -775.2% | -832.4% | -573.6% | -665.0% | -125.3% | -99.7% | -295.1% | -351.2% | -244.3% | -367.5% | -431.6% | -900.3% | -1,166.8% | -1,146.9% | -1,472.5% | -796.2% | -1,390.4% | 23.5% | -1,463.5% | -357.4% | 94.7% | -507.2% | 84.2% | |
| -2,494.1% | – | -7,766.4% | -1,704.2% | -158.6% | -2,350.3% | -1,164.6% | -1,518.2% | -1,780.6% | -1,050.2% | -3,347.6% | -3,492.8% | -3,056.3% | -783.5% | -826.3% | -824.8% | -1,128.8% | -657.5% | -714.8% | -751.9% | -537.4% | -629.3% | -82.8% | -93.6% | -282.2% | -330.6% | -236.4% | -356.5% | -422.7% | -939.9% | -1,140.7% | -1,124.3% | -1,445.3% | -974.3% | -1,369.9% | 23.9% | -1,457.1% | -354.6% | 94.8% | -504.3% | 84.3% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.